Boston Scientific Corp (XTER:BSX)
€ 86.5 -0.5 (-0.57%) Market Cap: 126.52 Bil Enterprise Value: 134.81 Bil PE Ratio: 74.93 PB Ratio: 6.45 GF Score: 79/100

Boston Scientific Corp at Jefferies Healthcare Conference (Virtual) Transcript

Jun 02, 2020 / 12:00PM GMT
Rajbir Singh Denhoy
Jefferies LLC, Research Division - MD, Equity Research & Senior Equity Research Analyst

Thanks, everyone, for joining us today at the Jefferies 2020 Virtual Healthcare Conference. I'm Raj Denhoy from the medical device research team. Now we realize it's kind of unprecedented time, so we appreciate everyone joining us this morning for the presentation. We have Boston Scientific this morning. We have the Rhythm Management and EP team. Joe Fitzgerald, the President; Ken Stein, the Chief Medical Officer; we have Mark Bickel, who's VP of Finance; and also Susie Lisa, who does IR.

Now before we dig into some questions, I think Joe and Ken had some comments they want to make, and so I'll turn it over to you, Joe.

Joseph M. Fitzgerald
Boston Scientific Corporation - Executive VP & President of Interventional Cardiology

Thanks, Raj, and thanks for having us. Wish we could be there in person, but I guess 12 weeks now living in the virtual world is -- we're kind of getting used to this.

Just a couple of quick statements

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot